Chongqing Pharmaceutical Research Institute competitive analysis

Explore Chongqing Pharmaceutical Research Institute's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
Nov 11, 2020Stable Composition Of Rasagiline1

Latest PTAB cases involving Chongqing Pharmaceutical Research Institute

Discover the latest PTAB cases involving Chongqing Pharmaceutical Research Institute, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Chongqing Pharmaceutical Research Institute with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE - 1 - -
GENERICS UK TRADING MYLAN48 - - -